Polysaccharopeptide

云芝胞内糖肽

Report date: 2025/07/14 17:58:26

Base Information

Drug NamePolysaccharopeptide
Drug Alias NameN/A
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesLiver NeoplasmsHepatitis B, Chronic
Global Approved IndicationsImmune System DiseasesLiver NeoplasmsHepatitis B, Chronic
Approved Indications in ChinaImmune System DiseasesLiver NeoplasmsHepatitis B, Chronic
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGuangxi Bangqi Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesLiver NeoplasmsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A